Abstract P27: Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic
Volume: 27, Issue: 6_Supplement, Pages: P27 - P27
Published: Mar 15, 2021
Abstract
Background: For cancer patients' treatment, coronavirus disease 2019 (COVID-19) poses a great challenge. COVID-19 presents as a severe respiratory infection in aging individuals, including patients with lung cancer. COVID-19 may be linked to the progression of aggressive lung cancer. Conversely, chemotherapy's side effects, such as chemotherapy resistance, acceleration of cellular senescence, could worsen COVID-19. Considering the...
Paper Details
Title
Abstract P27: Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic
Published Date
Mar 15, 2021
Journal
Volume
27
Issue
6_Supplement
Pages
P27 - P27
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History